Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 9
Case report
Dramatic response to alectinib in a lung cancer patient with a novel VKORC1L1-ALK fusion and an acquired ALK T1151K mutation
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,636 | Dovepress* | 6,388+ | 983 | 7,371 | |
| PubMed Central* | 1,248 | 191 | 1,439 | ||
| Totals | 7,636 | 1,174 | 8,810 | ||
| *Since 8 November 2018 | |||||
View citations on PubMed Central and Google Scholar